Pharmacy

Coverage of circulating tumor cell (CTC) assays could be discontinued for beneficiaries in certain states.

Both the clinical potential and costs associated with specialty drugs have grown rapidly over a relatively short period of time.

19 out of 20 patients who think they are allergic to penicillin are wrong and are costing 63% more

Why would HHS disrupt Part D when it's been a success for plans and for seniors?

AMCP and NCPA are generally relieved that feds won't interfere with drug prices

Narrow pharmacy networks are booming

Drug shortages remain a serious problem for patient safety, according to newly published results from a survey of pharmacy directors.

Six protected drug classes could be whittled down to three by 2016

Get caught up on CMS proposals for Part D networks, mail order and price negotiations

Breakthrough Therapy Designation given to daclatasvir and asunaprevir

Hep C drugs offer significant advantages, but payers must define payment approaches for optimal utilization.

Industry sounds off on healthcare using hashtag on Valentine's day; goes viral.

Drug prices show staggering markup

PBMs are moving products to non-covered status

Those treated with Umeclidinium and vilanterol inhalation powder showed improved lung function.

The two companies have signed an agreement that commits them to a “50/50 joint venture” that may dominate the US market.

Manufacturers must prove products are more effective than soap and water.

Chain and independent pharmacies aim to retain customers

Fear and dosing schedules are barriers

Discussion leaves a sense of uncertainty as to how coverage rules will play out

Surgery patients are at risk for addiction and overdose

Four criteria

How e-cigarettes compare to approved smoking cessation therapies is an unknown

Will ACA exchanges earn 90% satisfaction ratings someday?

Diabetes patients under 65 had significantly fewer emergency room visits when using mail order pharmacy.